Vital Signsby BridgeheadAll voices

01  Voice · Clinician · Diabetes

Jennifer Snaith: no photograph is held, so the clinician plate is shown instead.
Clinician

Jennifer Snaith

Dr, co-leader of the study, Garvan Institute of Medical Research

Press citations per month · linked articles
0
0
0
0
0
0
0
0
0
0
0
0
Dec 2025Jan 2026FebMarAprMayJuneJulyAugSeptOctNovto date
4

press citations on 1 topic since 24 Nov 2025 · last quoted 30 Nov 2025

02  Quoted on · 1 of 29 topics

Open the topic

Jennifer Snaith: key facts

Kind of voice
Clinician
Role
Dr, co-leader of the study, Garvan Institute of Medical Research
Quoted on
Diabetes
Tracked press citations
4
Most recently quoted
30 Nov 2025
First quoted
24 Nov 2025

04  The signal · where Jennifer Snaith sits on diabetes

Ranked 29= of 100 voices quoted in the press on diabetes, level with 18 others on 4 citations.

Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.

  1. 1Douglas Twenefour portraitDouglas TwenefourClinicianHead of Clinical, Diabetes UK36
  2. 2Dr Elizabeth Robertson portraitDr Elizabeth RobertsonSector leaderDirector of Research and Clinical, Diabetes UK20
  3. 3=Helen Knight portraitHelen KnightRegulatorDirector of Medicines Evaluation, National Institute for Health and Care Excellence (NICE)15
  4. 29=Sandra CohenSector leaderconsultant nutritionist listed on Doctify, a healthcare review platform4
  5. 29=Dr Robbie LyndsayAcademicNational Diabetes Lead, NHS Scotland4
  6. 29=Jennifer SnaithClinicianDr, co-leader of the study, Garvan Institute of Medical Research4
  7. 29=Jerry GreenfieldAcademicProfessor, Garvan Institute of Medical Research4
  8. 48=Henry GreggSector leaderChief Executive, National Pharmacy Association3

Showing the leaders and the ranks around 29=, of 100 voices · See every voice on the topic →

05  On the record · press

What Jennifer Snaith has said

By outlet · linked articles
  • bristolpost.co.uk1
  • getsurrey.co.uk1
  • mirror.co.uk1
  • technologynetworks.com1

Verbatim

“Insulin resistance is a growing problem in type 1 diabetes. Not only does it make regulating blood sugar levels difficult, but it is an underappreciated risk factor for heart disease, which is one of the biggest causes of health complications and deaths in those with type 1 diabetes.”
Dr, co-leader of the study, Garvan Institute of Medical Research · Diabetes · mirror.co.uk · 30 Nov 2025 · Read the article
“Insulin resistance is a growing problem in type 1 diabetes. Not only does it make regulating blood sugar levels difficult, but it is an underappreciated risk factor for heart disease, which is one of the biggest causes of health complications and deaths in those with type 1 diabetes.”
Dr, study co-leader, Garvan Institute of Medical Research · Diabetes · getsurrey.co.uk · 30 Nov 2025 · Read the article
“Insulin resistance is a growing problem in T1D. Not only does it make regulating blood sugar levels difficult, but it is an underappreciated risk factor for heart disease, which is one of the biggest causes of health complications and deaths in those with T1D”
Endocrinologist and research fellow, Garvan Institute of Medical Research · Diabetes · technologynetworks.com · 27 Nov 2025 · Read the article
“we did show that people taking it used around 12% less insulin than those on placebo.”
Dr, study co-leader, Garvan Institute of Medical Research · Diabetes · bristolpost.co.uk · 24 Nov 2025 · Read the article

Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.